| Pharmacologic treatment of pediatric insomnia. | |
| | |
MedLine Citation:
|
PMID: 19836701 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Pediatric insomnia is common in children and adolescents, particularly in children who have comorbid medical, psychiatric, and neurodevelopmental disorders, and may be associated with cognitive, emotional, and psychosocial impairments that often result in significant caregiver burden. Although several behavioral interventions for pediatric insomnia are effective, there is a relative paucity of empiric evidence supporting the use of pharmacologic treatment. Sedative/hypnotic drugs are frequently used in clinical practice to treat pediatric insomnia, and guidelines for the use of these medications in general as well as for specific medications have been developed. This review presents expert consensus guidelines for the use of these medications in clinical practice, with a focus on the different classes of pharmacologic agents that are most commonly prescribed. |
| | |
Authors:
|
Judith A Owens; Sricharan Moturi |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Child and adolescent psychiatric clinics of North America Volume: 18 ISSN: 1558-0490 ISO Abbreviation: Child Adolesc Psychiatr Clin N Am Publication Date: 2009 Oct |
Date Detail:
|
Created Date: 2009-10-19 Completed Date: 2009-12-30 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9313451 Medline TA: Child Adolesc Psychiatr Clin N Am Country: United States |
Other Details:
|
Languages: eng Pagination: 1001-16 Citation Subset: IM |
Affiliation:
|
Department of Pediatrics, Alpert Medical School at Brown University, Ambulatory Pediatrics Potter 200, 593 Eddy Street, Providence, RI 02903, USA. owensleep@gmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adrenergic alpha-Agonists / adverse effects, therapeutic use Anticonvulsants / adverse effects, therapeutic use Antidepressive Agents / adverse effects, therapeutic use Antipsychotic Agents / adverse effects, therapeutic use Behavior Therapy Child Comorbidity Evidence-Based Medicine Histamine H1 Antagonists / adverse effects, therapeutic use Humans Hypnotics and Sedatives / adverse effects, therapeutic use* Melatonin / adverse effects, therapeutic use Patient Care Team Plant Preparations / adverse effects, therapeutic use Practice Guidelines as Topic Referral and Consultation Sleep Initiation and Maintenance Disorders / drug therapy*, etiology |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic alpha-Agonists; 0/Anticonvulsants; 0/Antidepressive Agents; 0/Antipsychotic Agents; 0/Histamine H1 Antagonists; 0/Hypnotics and Sedatives; 0/Plant Preparations; 73-31-4/Melatonin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Insomnias of childhood and adolescence.
Next Document: Emerging medicolegal issues in the practice of pediatric sleep medicine.